RTC
CERE

Riverview Trust Company’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-385
Closed -$15.7K 859
2024
Q2
$15.7K Hold
385
0.01% 533
2024
Q1
$16.3K Buy
+385
New +$16.3K 0.01% 565